🚀Enjoy a 7-Day Free Trial Until Jul 20, 2024!

CO

Collegium Pharmaceutical IncNASDAQ COLL Stock Report

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is COLL undervalued compared to its fair value?

The fair value of COLL stock is hidden USD. Relative to the market price of 31.78 USD Collegium Pharmaceutical Inc is hidden.

Collegium Pharmaceutical, Inc. operates as a pharmaceutical company. The company is headquartered in Stoughton, Massachusetts and currently employs 207 full-time employees. The company went IPO on 2015-05-07. The firm co...[More about valuation]

Collegium Pharmaceutical Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

1.043 $B

Price:

31.78 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

0.669

FINANCIALS

Collegium Pharmaceutical financial for reporting period

Income Statement

0.14 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.049 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.028 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.14 B 100%
0.091 B 63%
0.028 B 19%

Balance Sheet

1.1 B
0.22 B


Financial Position Analysis

Assets

1.1 B
Current Assets
0.54 B
Total non-current assets
0.57 B

Total current liabilities
0.45 B
Total non-current liabilities
0.45 B

Cash Flow Statement

0.016 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.062 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Collegium Pharmaceutical fundamental analysis for trailing twelve months (TTM)

Profitability score


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

47 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
23 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
8 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is COLL attractive for investment based on fundamental analysis?

COLL stock rating is hidden. Collegium Pharmaceutical is a hidden by Eyestock methodology.

Get COLL Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

16

Gross Margin:

60

CFO / Debt ratio:

hidden

Current ratio:

1.192

Debt / Equity ratio:

3.457

ROE:

47

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

COLL analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for COLL to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Collegium Pharmaceutical Inc competitors

LL

LLY

Eli Lilly and Co

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs ...

Discover

NO

NOVO B.CO

Novo Nordisk A/S

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. The firm is also engaged i...

Discover

JN

JNJ

Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. The company is headquartered in Ne...

Discover

Collegium Pharmaceutical Inc dividends

COLL dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About COLL stock

About the company Collegium Pharmaceutical Inc

Market cap $B

1.043

Dividend yield

Shares outstanding

34.0666 B

Collegium Pharmaceutical, Inc. operates as a pharmaceutical company. The company is headquartered in Stoughton, Massachusetts and currently employs 207 full-time employees. The company went IPO on 2015-05-07. The firm commercializes its pain portfolio, consisting of Xtampza extended-release (ER), Nucynta Products, Belbuca, and Symproic in the United States. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone. Xtampza ER is for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The Nucynta Products are extended-release (ER) and immediate-release (IR) formulations of tapentadol. Nucynta ER is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. Nucynta IR is indicated for the management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate in adults. Belbuca is a buccal film that contains buprenorphine, a partial opioid agonist. Symproic is an oral formulation of naldemedine.

COLL profile

  • Ticker

    COLL

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    07 May 2015

  • Sector

    Healthсare

  • Industry

    Pharmaceuticals

  • Employees

    207

  • City

    Stoughton

  • Address

    100 Technology Center Dr

  • Cusip

    19459J104